Kala Bio announced that CHASE (NCT05727878), its phase 2b clinical trial of KPI-012 for persistent corneal epithelial defect ...
Explore the Fight Retinal Blindness! Project, a global registry enhancing VEGF inhibitor treatment outcomes with ...
Canadian medical device company MacuMira Medical Devices recently introduced the first Health Canada-approved treatment to ...
“Pattern recognition is key,” emphasized Prem S. Subramanian, MD, PhD, as he discussed the challenges of distinguishing ...
Can you share some highlights from the BETTER study with us? Marion Munk, MD, PhD: I'm very excited about this project. We ...
Explore how digital image management and AI transform ophthalmology, enhancing diagnostics and personalizing patient care in retina practices.
The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals' Abbreviated New Drug Application (ANDA) for ...
A study of the effects of repetitive impacts to the head during one season of football found that the smooth pursuit velocity ...
Their answers reflect the diversity of challenges facing ophthalmologists today, from the most common causes of vision loss ...
The US Food and Drug Administration (FDA) has granted Priority Review to Chiesi Global Rare Diseases’ idebenone for Leber ...
STAAR and Broadwood Partners have recently pleaded their case in the proposed merger between STAAR and Alcon, issuing ...
Research on methotrexate's role in PVR retinal detachment surgery shows promising visual improvements, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback